Work

Abstract IA016: Resistance to ALK-targeting therapies in lung cancers is acquired through complex, context specific evolutionary trajectories

Year: 2022

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.evodyn22-ia016

Author: Andriy Marusyk

Institution: Moffitt Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4280506270

Cites:

Cited by:

Related to: 10